Synapse - Ferrata Storti Foundation

Results (320)

Final analysis of the phase III non-inferiority COLUMBA study of subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma

Journal Article

Usmani, S. Z.; Nahi, H.; Legiec, W.; Grosicki, S.; Vorobyev, V.; Spicka, I.; Hungria, V.; Korenkova, S.; Bahlis, N. J.; Flogegard, M.; more...
Haematologica (2022)

Fulltext@MSK | Save

Genetic and genomic analysis of acute lymphoblastic leukemia in older adults reveals a distinct profile of abnormalities: Analysis of 210 patients from the UKALL14 and UKALL60+clinical trials

Journal Article

Creasey, T.; Barretta, E.; Ryan, S. L.; Butler, E.; Kirkwood, A. A.; Leongamornlert, D.; Papaemmanuil, E.; Patrick, P.; Clifton-Hadley, L.; Patel, B.; more...
Haematologica (2022)

Fulltext@MSK | Save

A clinical practice comparison of patients with chronic lymphocytic leukemia with and without deletion 17p receiving first-line treatment with ibrutinib

Journal Article

Mato, A. R.; Tang, B.; Azmi, S.; Yang, K.; Zhang, X.; Stern, J. C.; Hedrick, E.; Huang, J.; Sharman, J. P.
Haematologica (2022)

Fulltext@MSK | Save

Discordant SARS-CoV-2 spike protein receptor binding domain IgG and neutralization after B-cell depletion

Journal Article

Noy, A.; Vardhana, S. A.
Haematologica (2022)

Fulltext@MSK | Save

Investigational venetoclax combination therapy in acute myeloid leukemia - A systematic review and meta-analysis

Research Letter

Shimony, S.; Rozental, A.; Bewersdorf, J. P.; Goldberg, A. D.; Stein, E. M.; Grimshaw, A. A.; Stone, R. M.; DeAngelo, D. J.; Wolach, O.; Stahl, M.
Haematologica (2022)

Fulltext@MSK | Save

Patient- and physician-reported pain after tyrosine kinase inhibitor discontinuation among patients with chronic myeloid leukemia

Journal Article

Flynn, K. E.; Atallah, E.; Lin, L.; Shah, N. P.; Silver, R. T.; Larson, R. A.; Pinilla-Ibarz, J.; Thompson, J. E.; Oehler, V. G.; Radich, J. P.; more...
Haematologica (2022)

Fulltext@MSK | Save

Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: A Therapeutic Advances in Childhood Leukemia Consortium trial (TACL 2014-001)